Xiaoteng Cui

1.6k total citations
40 papers, 932 citations indexed

About

Xiaoteng Cui is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xiaoteng Cui has authored 40 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Cancer Research and 13 papers in Immunology. Recurrent topics in Xiaoteng Cui's work include Cancer Mechanisms and Therapy (11 papers), Glioma Diagnosis and Treatment (10 papers) and Cancer-related molecular mechanisms research (8 papers). Xiaoteng Cui is often cited by papers focused on Cancer Mechanisms and Therapy (11 papers), Glioma Diagnosis and Treatment (10 papers) and Cancer-related molecular mechanisms research (8 papers). Xiaoteng Cui collaborates with scholars based in China, Canada and Montenegro. Xiaoteng Cui's co-authors include Chunsheng Kang, Qixue Wang, Yanli Tan, Jie Yang, Chuan Fang, Xingjie Gao, Yunfei Wang, Kaikai Yi, Shixue Yang and Can Xu and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and FEBS Letters.

In The Last Decade

Xiaoteng Cui

38 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoteng Cui China 19 611 386 142 142 135 40 932
Kelly C. Goldsmith United States 19 543 0.9× 165 0.4× 149 1.0× 237 1.7× 150 1.1× 48 911
Vida Vafaizadeh Germany 17 675 1.1× 334 0.9× 106 0.7× 409 2.9× 148 1.1× 25 1.1k
Maheedhara R. Guda United States 18 488 0.8× 329 0.9× 161 1.1× 245 1.7× 250 1.9× 27 917
Francesca Pedini Italy 14 626 1.0× 426 1.1× 117 0.8× 180 1.3× 177 1.3× 21 973
Stefania Trino Italy 19 786 1.3× 425 1.1× 156 1.1× 148 1.0× 140 1.0× 41 1.0k
Aifa Tang China 18 647 1.1× 423 1.1× 54 0.4× 136 1.0× 128 0.9× 50 988
Chen Zhu China 16 343 0.6× 208 0.5× 100 0.7× 180 1.3× 164 1.2× 35 680
Francesco Paolo Tambaro United States 16 789 1.3× 160 0.4× 262 1.8× 309 2.2× 187 1.4× 40 1.3k
Linda Pestano United States 14 694 1.1× 483 1.3× 52 0.4× 71 0.5× 97 0.7× 25 990
Manoj M. Pillai United States 18 557 0.9× 236 0.6× 133 0.9× 231 1.6× 141 1.0× 39 897

Countries citing papers authored by Xiaoteng Cui

Since Specialization
Citations

This map shows the geographic impact of Xiaoteng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoteng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoteng Cui more than expected).

Fields of papers citing papers by Xiaoteng Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoteng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoteng Cui. The network helps show where Xiaoteng Cui may publish in the future.

Co-authorship network of co-authors of Xiaoteng Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoteng Cui. A scholar is included among the top collaborators of Xiaoteng Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoteng Cui. Xiaoteng Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xilei, Yalong Gao, Lei Li, et al.. (2025). Glioblastoma Cells Express and Secrete Alternatively Spliced Transcripts of Coagulation Factor X. Biomedicines. 13(3). 576–576.
2.
Qian, Baoxin, Yan Zhao, Xinxin Zhang, et al.. (2025). Tudor staphylococcal nuclease (Tudor‐ SN ) regulates activation of quiescent hepatic stellate cells. FEBS Journal. 292(13). 3545–3564.
3.
Zhang, Xinxin, Xiaoteng Cui, Peiying Li, et al.. (2024). EGC enhances tumor antigen presentation and CD8+ T cell-mediated antitumor immunity via targeting oncoprotein SND1. Cancer Letters. 592. 216934–216934. 5 indexed citations
4.
Yang, Eryan, Biao Hong, Yunfei Wang, et al.. (2024). EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma. Cancer Letters. 588. 216812–216812. 10 indexed citations
5.
Cui, Xiaoteng, et al.. (2024). Levetiracetam: A Potent Sword against Microglia Polarization in Gliomas. Clinical Cancer Research. 30(6). 1073–1075. 2 indexed citations
6.
Cui, Xiaoteng & Chunsheng Kang. (2024). Stressing the Role of CCL3 in Reversing the Immunosuppressive Microenvironment in Gliomas. Cancer Immunology Research. 12(5). 514–514. 3 indexed citations
7.
Cui, Xiaoteng, Dawei Huo, Qixue Wang, et al.. (2024). RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma. Cell Death and Disease. 15(1). 98–98. 13 indexed citations
8.
Cui, Xiaoteng, Jixing Zhao, Guanzhang Li, et al.. (2023). Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma. Cancer Communications. 43(12). 1326–1353. 22 indexed citations
9.
Lei, Xin, Yanli Tan, Xiaoteng Cui, et al.. (2023). EPIC-0307-mediated selective disruption of PRADX–EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMT. Neuro-Oncology. 25(11). 1976–1988. 12 indexed citations
10.
Cui, Xiaoteng, Yunfei Wang, Junhu Zhou, Qixue Wang, & Chunsheng Kang. (2023). Expert opinion on translational research for advanced glioblastoma treatment. Cancer Biology and Medicine. 20(5). 1–9. 13 indexed citations
11.
Xu, Can, Jixing Zhao, Jia L. Song, et al.. (2022). lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted Therapy. Frontiers in Oncology. 12. 888922–888922. 13 indexed citations
12.
Yang, Eryan, Lin Wang, Weili Jin, et al.. (2022). PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma. Theranostics. 12(9). 4330–4347. 27 indexed citations
13.
Yang, Shixue, Jixing Zhao, Xiaoteng Cui, et al.. (2022). TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma. Theranostics. 12(16). 7032–7050. 36 indexed citations
14.
Zhao, Chunyan, Xiaoteng Cui, Baoxin Qian, et al.. (2021). Impact of hepatocyte-specific deletion of staphylococcal nuclease and tudor domain containing 1 (SND1) on liver insulin resistance and acute liver failure of mice. Bioengineered. 12(1). 7360–7375. 4 indexed citations
15.
Li, Yansheng, Xing Liu, Xiaoteng Cui, et al.. (2021). LncRNA PRADX-mediated recruitment of PRC2/DDX5 complex suppresses UBXN1 expression and activates NF-κB activity, promoting tumorigenesis. Theranostics. 11(9). 4516–4530. 45 indexed citations
16.
Wang, Xinting, Xiaoteng Cui, Yue Zhuo, et al.. (2020). Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8 + T cell response in tumor. Science Advances. 6(22). 33 indexed citations
17.
Su, Chao, Mingxia Liu, Xiaoteng Cui, et al.. (2020). Translation of Tudor-SN, a novel terminal oligo-pyrimidine (TOP) mRNA, is regulated by the mTORC1 pathway in cardiomyocytes. RNA Biology. 18(6). 900–913. 5 indexed citations
18.
Cui, Xiaoteng, Xinxin Zhang, Minghui Liu, et al.. (2020). A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors. Genomics. 112(6). 3958–3967. 111 indexed citations
19.
Zhao, Kai, Xiaoteng Cui, Qixue Wang, et al.. (2019). RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner. Cell Death and Disease. 10(12). 877–877. 52 indexed citations
20.
Su, Chao, Xingjie Gao, Yali Zhao, et al.. (2016). Phosphorylation of Tudor-SN, a novel substrate of JNK, is involved in the efficient recruitment of Tudor-SN into stress granules. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1864(3). 562–571. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly C. Goldsmith Breakdown of academic impact, for papers by Vida Vafaizadeh Breakdown of academic impact, for papers by Maheedhara R. Guda Breakdown of academic impact, for papers by Francesca Pedini Breakdown of academic impact, for papers by Stefania Trino Breakdown of academic impact, for papers by Aifa Tang Breakdown of academic impact, for papers by Chen Zhu Breakdown of academic impact, for papers by Francesco Paolo Tambaro Breakdown of academic impact, for papers by Linda Pestano Breakdown of academic impact, for papers by Manoj M. Pillai
Rankless by CCL
2026